The European Medicines Agency is expected to approve Johnson & Johnson’s Covid-19 vaccine in early March, which is expected to start being distributed by the European Union by April, the French Industry Minister said on Sunday.
The European Union’s green light will be granted “in early March, as the European Medicines Agency is reviewing all the information that Johnson & Johnson has communicated to it in order to place this vaccine on the market,” Agnès Pannier-Runacher told the channel France 3 television channel.
The minister said that the first doses should “arrive in late March or early April because there is a deadline for the production of doses”, which “is still under discussion with the laboratory”.
“This is very good news because this vaccine is a single dose, but it is possible that you need reinforcements, we still don’t know”, he warned.
On Saturday, the US drug regulator approved the Johnson & Johnson single-dose vaccine for people over 18, making it the third approved vaccine in the country, in addition to Pfizer / BioNTech and Moderna.
The French minister said that the plan involves the arrival in Europe of 600 million doses of vaccines against Covid-19 by the end of June.
According to the United States drug authority, the vaccine produced by drugmaker Janssen, of the Johnson & Johnson group, protects against severe Covid-19.
According to the final clinical trials, a dose is 85% effective against the most serious manifestations of the disease.
The Covid-19 pandemic caused at least 2,526,075 deaths worldwide, resulting from more than 113.7 million cases of infection, according to a report made by the French agency AFP.
In Portugal, 16,317 people died from 804,562 confirmed cases of infection, according to the most recent bulletin from the Directorate-General for Health.
The disease is transmitted by a new coronavirus detected in late December 2019 in Wuhan, a city in central China.
In the most severe cases, the infection can lead to death.
Source: Renascença – Noticias by rr.sapo.pt.
*The article has been translated based on the content of Renascença – Noticias by rr.sapo.pt. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!